BMRN logo

BioMarin Pharmaceutical (BMRN) Retained earnings

annual retained earnings:

-$194.69M+$426.86M(+68.68%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BMRN annual retained earnings is -$194.69 million, with the most recent change of +$426.86 million (+68.68%) on December 31, 2024.
  • During the last 3 years, BMRN annual retained earnings has risen by +$736.07 million (+79.08%).
  • BMRN annual retained earnings is now -1189.37% below its all-time high of -$15.10 million, reached on December 31, 1998.

Performance

BMRN Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

quarterly retained earnings:

-$9.01M+$185.69M(+95.37%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN quarterly retained earnings is -$9.01 million, with the most recent change of +$185.69 million (+95.37%) on March 31, 2025.
  • Over the past year, BMRN quarterly retained earnings has increased by +$523.88 million (+98.31%).
  • BMRN quarterly retained earnings is now at all-time high.

Performance

BMRN quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

BMRN Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+68.7%+98.3%
3 y3 years+79.1%+98.9%
5 y5 years+88.7%+99.5%

BMRN Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+79.1%at high+98.9%
5 y5-yearat high+88.7%at high+99.5%
alltimeall time-1189.4%+88.7%at high+99.5%

BMRN Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$9.01M(-95.4%)
Dec 2024
-$194.69M(-68.7%)
-$194.69M(-39.1%)
Sep 2024
-
-$319.64M(-24.9%)
Jun 2024
-
-$425.72M(-20.1%)
Mar 2024
-
-$532.89M(-14.3%)
Dec 2023
-$621.55M(-21.2%)
-$621.55M(-3.2%)
Sep 2023
-
-$641.93M(-5.9%)
Jun 2023
-
-$682.31M(-7.6%)
Mar 2023
-
-$738.35M(-6.4%)
Dec 2022
-$789.20M(-15.2%)
-$789.20M(+0.0%)
Sep 2022
-
-$788.95M(+1.5%)
Jun 2022
-
-$777.23M(-3.4%)
Mar 2022
-
-$804.89M(-13.5%)
Dec 2021
-$930.76M(+8.0%)
-$930.76M(+7.3%)
Sep 2021
-
-$867.79M(+4.4%)
Jun 2021
-
-$831.30M(-1.5%)
Mar 2021
-
-$844.24M(-2.0%)
Dec 2020
-$861.61M(-49.9%)
-$861.61M(-2.5%)
Sep 2020
-
-$883.71M(-47.0%)
Jun 2020
-
-$1.67B(+1.8%)
Mar 2020
-
-$1.64B(-4.7%)
Dec 2019
-$1.72B(+1.6%)
-$1.72B(-0.9%)
Sep 2019
-
-$1.74B(-3.1%)
Jun 2019
-
-$1.79B(+2.1%)
Mar 2019
-
-$1.75B(+3.5%)
Dec 2018
-$1.69B(+3.5%)
-$1.69B(+0.2%)
Sep 2018
-
-$1.69B(+0.8%)
Jun 2018
-
-$1.68B(+1.0%)
Mar 2018
-
-$1.66B(+1.4%)
Dec 2017
-$1.64B(+7.7%)
-$1.64B(+3.2%)
Sep 2017
-
-$1.59B(+0.8%)
Jun 2017
-
-$1.57B(+2.4%)
Mar 2017
-
-$1.54B(+1.1%)
Dec 2016
-$1.52B(+48.8%)
-$1.52B(-3.3%)
Sep 2016
-
-$1.57B(+2.8%)
Jun 2016
-
-$1.53B(+38.3%)
Mar 2016
-
-$1.11B(+8.3%)
Dec 2015
-$1.02B(+20.2%)
-$1.02B(-6.3%)
Sep 2015
-
-$1.09B(+9.1%)
Jun 2015
-
-$999.26M(+8.9%)
Mar 2015
-
-$917.27M(+7.9%)
Dec 2014
-$849.77M(+18.7%)
-$849.77M(+8.9%)
Sep 2014
-
-$779.97M(-0.9%)
Jun 2014
-
-$787.42M(+4.4%)
Mar 2014
-
-$753.92M(+5.3%)
Dec 2013
-$715.80M(+32.7%)
-$715.80M(+9.5%)
Sep 2013
-
-$653.81M(+8.8%)
Jun 2013
-
-$600.79M(+3.7%)
Mar 2013
-
-$579.26M(+7.4%)
Dec 2012
-$539.45M(+26.9%)
-$539.45M(+10.9%)
Sep 2012
-
-$486.44M(+1.1%)
Jun 2012
-
-$481.08M(+7.1%)
Mar 2012
-
-$449.07M(+5.6%)
DateAnnualQuarterly
Dec 2011
-$425.10M(+14.5%)
-$425.10M(+6.7%)
Sep 2011
-
-$398.37M(+4.6%)
Jun 2011
-
-$380.71M(+1.4%)
Mar 2011
-
-$375.64M(+1.2%)
Dec 2010
-$371.26M(-35.7%)
-$371.26M(+3.4%)
Sep 2010
-
-$359.08M(-37.7%)
Jun 2010
-
-$576.41M(+0.1%)
Mar 2010
-
-$575.93M(-0.2%)
Dec 2009
-$577.08M(+0.1%)
-$577.08M(-0.8%)
Sep 2009
-
-$581.79M(-1.1%)
Jun 2009
-
-$588.44M(-0.2%)
Mar 2009
-
-$589.75M(+2.3%)
Dec 2008
-$576.60M(-5.1%)
-$576.60M(-4.1%)
Sep 2008
-
-$601.10M(-0.1%)
Jun 2008
-
-$601.93M(-0.6%)
Mar 2008
-
-$605.74M(-0.3%)
Dec 2007
-$607.43M(+2.7%)
-$607.43M(-0.4%)
Sep 2007
-
-$610.00M(+0.9%)
Jun 2007
-
-$604.78M(+0.6%)
Mar 2007
-
-$600.92M(+1.6%)
Dec 2006
-$591.62M(+5.1%)
-$591.62M(+1.8%)
Sep 2006
-
-$581.23M(+1.2%)
Jun 2006
-
-$574.20M(+0.2%)
Mar 2006
-
-$572.87M(+1.7%)
Dec 2005
-$563.09M(+15.2%)
-$563.09M(+2.7%)
Sep 2005
-
-$548.10M(+2.9%)
Jun 2005
-
-$532.62M(+4.2%)
Mar 2005
-
-$511.28M(+4.6%)
Dec 2004
-$488.82M(+62.2%)
-$488.82M(+20.3%)
Sep 2004
-
-$406.40M(+7.8%)
Jun 2004
-
-$376.92M(+17.3%)
Mar 2004
-
-$321.32M(+6.6%)
Dec 2003
-$301.38M(+33.6%)
-$301.38M(+9.3%)
Sep 2003
-
-$275.65M(+8.4%)
Jun 2003
-
-$254.36M(+3.7%)
Mar 2003
-
-$245.26M(+8.7%)
Dec 2002
-$225.58M(+52.3%)
-$225.58M(+9.4%)
Sep 2002
-
-$206.25M(+9.1%)
Jun 2002
-
-$189.13M(+8.2%)
Mar 2002
-
-$174.72M(+18.0%)
Dec 2001
-$148.12M(+84.0%)
-$148.12M(+30.9%)
Sep 2001
-
-$113.20M(+10.8%)
Jun 2001
-
-$102.18M(+13.3%)
Mar 2001
-
-$90.21M(+12.0%)
Dec 2000
-$80.51M(+86.6%)
-$80.51M(+14.8%)
Sep 2000
-
-$70.12M(+13.1%)
Jun 2000
-
-$61.97M(+12.9%)
Mar 2000
-
-$54.88M(+27.2%)
Dec 1999
-$43.15M(+185.8%)
-$43.15M(+26.5%)
Sep 1999
-
-$34.10M(+28.7%)
Jun 1999
-
-$26.50M(+35.2%)
Mar 1999
-
-$19.60M
Dec 1998
-$15.10M
-

FAQ

  • What is BioMarin Pharmaceutical annual retained earnings?
  • What is the all time high annual retained earnings for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual retained earnings year-on-year change?
  • What is BioMarin Pharmaceutical quarterly retained earnings?
  • What is the all time high quarterly retained earnings for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly retained earnings year-on-year change?

What is BioMarin Pharmaceutical annual retained earnings?

The current annual retained earnings of BMRN is -$194.69M

What is the all time high annual retained earnings for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual retained earnings is -$15.10M

What is BioMarin Pharmaceutical annual retained earnings year-on-year change?

Over the past year, BMRN annual retained earnings has changed by +$426.86M (+68.68%)

What is BioMarin Pharmaceutical quarterly retained earnings?

The current quarterly retained earnings of BMRN is -$9.01M

What is the all time high quarterly retained earnings for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly retained earnings is -$9.01M

What is BioMarin Pharmaceutical quarterly retained earnings year-on-year change?

Over the past year, BMRN quarterly retained earnings has changed by +$523.88M (+98.31%)
On this page